Remove Insurance Coverage Remove Pharmaceutical Companies Remove Presentation
article thumbnail

How much is Combivent Respimat without insurance?

The Checkup by Singlecare

Check your plan’s formulary for information on copays, coinsurance, and deductibles to get a better sense of what you might pay after insurance. Coverage may depend on how your plan classifies Combivent Respimat as well. Insurance companies have a tier system on medications,” says David Nazarian, MD , founder of My Concierge MD.

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What HCPs think about health equity in cancer care

pharmaphorum

Captured among HCP conversations was data from studies whose aim was to define the extent of disparities experienced across various groups as well as the input of organisations, including pharmaceutical companies, to advocate for, raise awareness and financially support these causes.

article thumbnail

Pharma’s ESG goals need to underscore push for health equity

Pharmaceutical Technology

Over recent years, many pharmaceutical companies have taken up environment, social and governance (ESG) targets in order to prioritize sustainability whilst boosting their external public relations. GlobalData is the parent company of Pharmaceutical Technology.

article thumbnail

GLP1 Receptor Agonist Market: Current Landscape, Growth Opportunities and Future Market Outlook

Roots Analysis

GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. GLP-1 Receptor Agonist Market – Current Landscape Presently, more than 150 GLP-1 drug candidates have been commercialized / being developed by more 55 developers to treat various metabolic disorders.

article thumbnail

Mounjaro vs. metformin: Key differences and which is better for you.

The Checkup by Singlecare

Choosing the right medication may involve weighing multiple factors, such as side effects, insurance coverage, and personal health goals. Mounjaro is a brand-name medication manufactured by Eli Lilly and Company. Metformin is a generic drug manufactured by various pharmaceutical companies.

article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises: “Evidence generation in drug development is ripe for innovation in the digital era and the expanded use of real-world evidence presents a clear enabler to saving time and money.

FDA